| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 11/01/2006 | CN1854289A Photosynthetic bacterial concentration |
| 11/01/2006 | CN1854288A Lucid ganoderma fungus with high glycopeptide composite yield, its mutagen breeding method and use |
| 11/01/2006 | CN1854285A Honeycomb-type fermentating technology of fungus insecticide liquid substrate culture medium |
| 11/01/2006 | CN1854157A Antibodies to insulin-like growth factor i receptor |
| 11/01/2006 | CN1853657A Use of three chromium-enriched biological materials in medicine for treating allergic rhinitis |
| 11/01/2006 | CN1282740C Pretreatment process for stabilizing beneficial microbe |
| 11/01/2006 | CN1282739C Fusarium capable of producing taxol |
| 11/01/2006 | CN1282658C Novel peptide, novel adsorbent, adsorption unit and adsorption method |
| 10/31/2006 | US7129344 Nucleic acid isolation |
| 10/31/2006 | US7129340 Point mutations; recombinant vectors/molecular targets; transcription factors |
| 10/31/2006 | US7129339 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 10/31/2006 | US7129337 Hepatitis C virus (HCV) polynucleic acid of given nucleotide sequence unique to at least one of the new HCV subtypes 7,9,10 OR 11, OR TO SUBTYPES 1D, 1E, 1F, 1G, 2E, 2F, 2G, 2H, 2I, 2K, 2L,3G,4K OR 4M; producing recombinant polypeptide |
| 10/31/2006 | US7129329 Heme proteins hemAT-Hs and hemAT-Bs and their use in medicine and microsensors |
| 10/31/2006 | US7129207 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders |
| 10/31/2006 | US7129088 Nucleic acid fragments encoding proteins involved in phenylpropanoid metabolism in plants and seeds |
| 10/31/2006 | US7129085 Polynucleotides encoding a human leucine-rich repeat domain containing protein, HLLRCR-1 |
| 10/31/2006 | US7129079 Cells engineered to contain genes of interest |
| 10/31/2006 | US7129077 Gene expression inhibition; solid phase synthesis; drug screening; for treating cancer, central nervous system disorders, and chronic obstructive pulmonary disorder |
| 10/31/2006 | US7129076 Multiply-substituted protease variants with altered net charge for use in detergents |
| 10/31/2006 | US7129074 Nucleoside triphosphate diphosphohydrolase (NTPDase 8) and uses thereof |
| 10/31/2006 | US7129071 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 10/31/2006 | US7129067 Method for producing lactone |
| 10/31/2006 | US7129066 Nucleotide sequences coding for the citE gene |
| 10/31/2006 | US7129065 bHLH-PAS proteins, genes thereof and utilization of the same |
| 10/31/2006 | US7129063 Junction-enriched and -associated protein (JEAP); antibodies for visualizing localization |
| 10/31/2006 | US7129062 Matrix attachment regions and methods for use thereof |
| 10/31/2006 | US7129061 Pure polypeptide containing a fragment capable of binding to and inducing apoptosis in a carcinoma cell; Tumor Necrosis Factor Related ligand or "TRELL", a polypeptide which is a member of the Tumor Necrosis Factor Family |
| 10/31/2006 | US7129060 Export systems for recombinant proteins |
| 10/31/2006 | US7129057 Human testis specific serine/threonine kinase 3 |
| 10/31/2006 | US7128919 Comprising amino acid sequences of streptococcal matrix adhesion (Ema) polypeptides |
| 10/31/2006 | CA2187927C Composition and method for controlling plant diseases |
| 10/31/2006 | CA2148482C Deblocking the common pathway of aromatic amino acid synthesis |
| 10/26/2006 | WO2006113668A1 A method of transdermal drug delivery using hyaluronic acid nanoparticles |
| 10/26/2006 | WO2006113601A2 Leptospirosis culture process |
| 10/26/2006 | WO2006113487A1 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 10/26/2006 | WO2006113147A2 Ascorbic acid production from d-glucose in yeast |
| 10/26/2006 | WO2006112360A1 Method of polonium gasification |
| 10/26/2006 | WO2006112040A1 NOVEL β-GALACOTSIDE-α-2,3-SIALYLTRANSFERASE, GENE ENCODING THE SAME AND METHOD OF PRODUCING THE SAME |
| 10/26/2006 | WO2006112025A1 NOVEL β-GALACTOSIDE-α-2,3-SIALYLTRANSFERASE, GENE ENCODING THE SAME AND METHOD FOR PRODUCING THE SAME |
| 10/26/2006 | WO2006112000A1 Method of synthesizing 2-deoxy-scyllo-inosose by modified strain of e. coli, method of purifying the same and obtained 2-deoxy-scyllo-inosose |
| 10/26/2006 | WO2006111372A2 Phytase |
| 10/26/2006 | WO2006111019A1 Mutant f. tularensis strain and uses thereof |
| 10/26/2006 | WO2006076343A8 Mycobacteria expressing hiv-1 and malaria antigens |
| 10/26/2006 | WO2006022882A3 Canine pancreatic lipse |
| 10/26/2006 | WO2005106011A3 Process for preparing dipeptidyl iv inhibitors and intermediates therefor |
| 10/26/2006 | WO2005086938A3 Artificial mutation controls for diagnostic testing |
| 10/26/2006 | WO2005035719A3 Modified luciferase |
| 10/26/2006 | WO2002101008A3 Intracellular signaling molecules |
| 10/26/2006 | US20060242738 Polynucleotides and polypeptides in plants |
| 10/26/2006 | US20060242735 Nucleic acid fragments encoding isoflavone synthase |
| 10/26/2006 | US20060242733 transformed plant comprising in its genome a stably incorporated nucleotide construct containing a nucleotide sequence that encodes a polypeptide that is pesticidal for pest belonging to the order Lepidoptera, coding sequence is operably linked to a promoter that drive expression in a plant cell |
| 10/26/2006 | US20060242732 encode pesticidal proteins; transgenic pest resistant plants |
| 10/26/2006 | US20060242730 Methods and compositions for tobacco plants with reduced nitrosamines |
| 10/26/2006 | US20060241291 Purified antibody, monoclonal antibody, or polyclonal antibody that binds to DES protein of Mycobacterium tuberculosis; medical diagnosis |
| 10/26/2006 | US20060240539 A Streptococcus thermophilus deposited on 26th Feb. 2003 at the Collection Nationale de Cultures de Microorganismes under number I-2980; extends shelf-life of dairy product; fermentation |
| 10/26/2006 | US20060240534 Process for producing scyllo-inositol |
| 10/26/2006 | US20060240533 Assembly for the stabilisation of vertebral bodies of the spine |
| 10/26/2006 | US20060240532 Amplification, translation, transcription |
| 10/26/2006 | US20060240528 Polyketides and their synthesis |
| 10/26/2006 | US20060240525 Factor VII or VIIa - Like Molecules |
| 10/26/2006 | US20060240524 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia |
| 10/26/2006 | US20060240522 Process for bacterial production of polypeptides |
| 10/26/2006 | US20060240521 DNA sequences for regulating transcription |
| 10/26/2006 | US20060240520 monitoring the efficacy of a BAFF-R (a B-cell activating factor belonging to the Tumor Necrosis Factor family) antagonist in the treatment of a disease or disorder associated with aberrant levels of B-cells or B-cell activity |
| 10/26/2006 | US20060240519 Novel receptor nucleic acids and polypeptides |
| 10/26/2006 | US20060240518 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
| 10/26/2006 | US20060240517 Novel receptor nucleic acids and polypeptides |
| 10/26/2006 | US20060240514 Fermentation of product for growth medium with reduced levels of animal meat or dairy product |
| 10/26/2006 | US20060240510 Method for designing peptides |
| 10/26/2006 | US20060240509 Myrothecium sp transformation and expression system |
| 10/26/2006 | US20060240508 By culturing yeast organisms that have an increased Delta 8-, Delta 7-, Delta 24-, Delta 5-isomerase and HMG-CoA-reductase activity |
| 10/26/2006 | US20060240506 Method for isolating and culturing unculturable microorganisms |
| 10/26/2006 | US20060240505 Identification of Targets of Antimicrobial Compounds |
| 10/26/2006 | US20060240502 GTP cyclohydrolase II as a target for fungicides |
| 10/26/2006 | US20060240491 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection |
| 10/26/2006 | US20060240472 Pigment protein |
| 10/26/2006 | US20060240470 Gene causative of Rothmund-Thomson syndrome and gene product |
| 10/26/2006 | US20060240465 CNG2B: a novel human cyclic nucleotide-gated ion channel |
| 10/26/2006 | US20060240449 Methods and compositions for preparation of biological samples |
| 10/26/2006 | US20060240448 Cell concentration and lysate clearance using paramagnetic particles |
| 10/26/2006 | US20060240414 Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 10/26/2006 | US20060240046 Live attenuated Leishmania vaccines |
| 10/26/2006 | US20060240045 Neisserial vaccine compositions comprising a combination of antigens |
| 10/26/2006 | US20060240044 Streptococcal superantigens spe-l and spe-m |
| 10/26/2006 | US20060240040 Optimized expression of hpv 45 l1 in yeast |
| 10/26/2006 | US20060240038 Cells used as carriers for bacteria |
| 10/26/2006 | US20060240036 I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis |
| 10/26/2006 | US20060240029 Chlamydia pneumoniae antigens |
| 10/26/2006 | US20060240018 Artificial antibody polypeptides |
| 10/26/2006 | US20060240015 Recombinant antibody against human insulin-like growth factor |
| 10/26/2006 | US20060240003 Humanised antibodies to the epidermal growth factor receptor |
| 10/26/2006 | US20060239991 polypeptide has the biological activity of methionyl tRNA synthetase; for the protection against bacterial infections |
| 10/26/2006 | US20060239978 Cellular expression of 65B13 in the neurons can be used as an index to select cells that are suitable in terms of their safety, survival rate, and network formation ability, for transplant therapy of neurodegenerative diseases such as Parkinson's disease |
| 10/26/2006 | DE19542786B4 Verbindungen mit bakterizider und/oder antimykotischer Aktivität, Herstellungsverfahren, Mittel und Mikroorganismenstamm Compounds with bactericidal and / or antifungal activity, manufacturing processes, resources and microorganism strain |
| 10/26/2006 | CA2608410A1 A novel .beta.-galactoside-.alpha.2, 3-sialyltransferase, a gene encoding thereof, and a method for producing thereof |
| 10/26/2006 | CA2606673A1 Mutant f. tularensis strain and uses thereof |
| 10/26/2006 | CA2605162A1 Methods and compositions to modulate adhesion and stress tolerance in bacteria |
| 10/25/2006 | EP1715050A1 Paraquat resistance gene and a vascular tissue- and trichome-specific promoter |
| 10/25/2006 | EP1715043A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 10/25/2006 | EP1715035A2 Synthetic polynucleotides encoding lysyl oxidase |